Intratumoral alterations of dendritic-cell differentiation and CD8+T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma

High DGK-  and Disabled MAPK Pathways Cause Dysfunction of Human Tumor-Infiltrating CD8+ T Cells That Is Reversible by Pharmacologic Intervention

(2012) P. U. Prinz et al.   JOURNAL OF IMMUNOLOGY

Human Renal Cell Carcinoma Induces a Dendritic Cell Subset That Uses T-Cell Crosstalk for Tumor-Permissive Milieu Alterations

(2011) Ainhoa-M. Figel et al.   AMERICAN JOURNAL OF PATHOLOGY

Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation

(2011) Anna N. Mendler et al.   INTERNATIONAL JOURNAL OF CANCER

Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging

(2011) Judith Eckl et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

T-Cell Receptor Gene-Modified T Cells with Shared Renal Cell Carcinoma Specificity for Adoptive T-Cell Therapy

(2010) M. Leisegang et al.   CLINICAL CANCER RESEARCH

The multikinase inhibitor Sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE2 in murine macrophages

(2010) Justin P. Edwards et al.   INTERNATIONAL IMMUNOPHARMACOLOGY